Keertik Fulzele

2.5k total citations · 1 hit paper
37 papers, 1.9k citations indexed

About

Keertik Fulzele is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Keertik Fulzele has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Hematology and 13 papers in Oncology. Recurrent topics in Keertik Fulzele's work include Bone Metabolism and Diseases (11 papers), Multiple Myeloma Research and Treatments (10 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Keertik Fulzele is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Multiple Myeloma Research and Treatments (10 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Keertik Fulzele collaborates with scholars based in United States, Australia and Austria. Keertik Fulzele's co-authors include Thomas L. Clemens, Douglas J. DiGirolamo, Xuemei Cao, Marie–Claude Faugere, Jens C. Brüning, Chao Wan, Susan Aja, Dongquan Chen, Ryan C. Riddle and Mehboob A. Hussain and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Keertik Fulzele

35 papers receiving 1.9k citations

Hit Papers

Insulin Receptor Signalin... 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition
    2010 603 citations Keertik Fulzele, Douglas J. DiGirolamo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keertik Fulzele United States 17 997 524 443 331 299 37 1.9k
Ingrid J. Poulton Australia 26 1.2k 1.2× 855 1.6× 306 0.7× 399 1.2× 127 0.4× 47 2.2k
Chris Pászty United States 19 1.6k 1.6× 771 1.5× 864 2.0× 297 0.9× 110 0.4× 25 2.5k
Angela Oranger Italy 23 738 0.7× 444 0.8× 184 0.4× 201 0.6× 46 0.2× 52 1.6k
S Bord United Kingdom 25 1.1k 1.1× 642 1.2× 470 1.1× 179 0.5× 284 0.9× 30 2.1k
Yuiko Sato Japan 23 649 0.7× 364 0.7× 321 0.7× 99 0.3× 61 0.2× 59 1.4k
Denise Dwyer United States 27 2.2k 2.2× 1.3k 2.4× 1.3k 2.8× 158 0.5× 203 0.7× 33 3.5k
Riku Kiviranta Finland 24 1.2k 1.2× 519 1.0× 356 0.8× 67 0.2× 68 0.2× 47 1.8k
Shinsuke Kido Japan 22 1.2k 1.2× 1.1k 2.1× 262 0.6× 686 2.1× 66 0.2× 49 2.4k
S. C. Manolagas United States 10 1.3k 1.3× 837 1.6× 786 1.8× 87 0.3× 186 0.6× 14 2.2k
Elizabeth Allan Australia 24 1.1k 1.1× 658 1.3× 146 0.3× 130 0.4× 103 0.3× 40 1.7k

Countries citing papers authored by Keertik Fulzele

Since Specialization
Citations

This map shows the geographic impact of Keertik Fulzele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keertik Fulzele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keertik Fulzele more than expected).

Fields of papers citing papers by Keertik Fulzele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keertik Fulzele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keertik Fulzele. The network helps show where Keertik Fulzele may publish in the future.

Co-authorship network of co-authors of Keertik Fulzele

This figure shows the co-authorship network connecting the top 25 collaborators of Keertik Fulzele. A scholar is included among the top collaborators of Keertik Fulzele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keertik Fulzele. Keertik Fulzele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamoto-Matsubara, Rie, Valentina Nardi, Nora Horick, et al.. (2024). Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma. Blood Cancer Journal. 14(1). 224–224. 2 indexed citations
2.
Ericsson, Anna, David J. Richard, Erik Wilker, et al.. (2024). FT-4202, a selective pyruvate kinase R activator for sickle cell disease. Experimental Hematology. 141. 104673–104673. 1 indexed citations
3.
Schroeder, Patricia, Keertik Fulzele, Maria Ribadeneira, et al.. (2022). Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. Journal of Pharmacology and Experimental Therapeutics. 380(3). 210–219. 28 indexed citations
4.
Mori, Tomoaki, Rakesh Verma, Rie Nakamoto-Matsubara, et al.. (2021). Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation. Blood Cancer Journal. 11(12). 194–194. 9 indexed citations
5.
6.
Panaroni, Cristina, et al.. (2020). A Novel in-Vivo Model to Examine Homing of Multiple Myeloma Cells in Postnatal, Inducible, and Reversible Loss of Mature Osteoblasts. Blood. 136(Supplement 1). 50–50. 1 indexed citations
7.
Panaroni, Cristina, Keertik Fulzele, Cherrie Huang, et al.. (2019). Polyunsaturated Fatty Acid (PUFA) Signaling Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma. Blood. 134(Supplement_1). 3108–3108. 8 indexed citations
8.
Fulzele, Keertik, et al.. (2018). Mature Osteoblasts Provide a Protective Niche Against Multiple Myeloma Growth and Survival within the Tumor Microenvironment. Blood. 132(Supplement 1). 4476–4476. 1 indexed citations
9.
Fulzele, Keertik, Forest Lai, Mary Bouxsein, et al.. (2018). Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity. Bone. 117. 138–148. 16 indexed citations
10.
Uda, Yuhei, Ningyuan Sun, Amira I. Hussein, et al.. (2017). Carbonic anhydrase III protects osteocytes from oxidative stress. The FASEB Journal. 32(1). 440–452. 28 indexed citations
11.
Saini, Vaibhav, Dean A. Marengi, Kevin J. Barry, et al.. (2013). Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH. Journal of Biological Chemistry. 288(28). 20122–20134. 115 indexed citations
12.
Krause, Daniela S., Keertik Fulzele, André Catic, et al.. (2013). Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nature Medicine. 19(11). 1513–1517. 207 indexed citations
13.
Fulzele, Keertik, Daniela S. Krause, Cristina Panaroni, et al.. (2012). Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling. Blood. 121(6). 930–939. 117 indexed citations
14.
Fulzele, Keertik & Thomas L. Clemens. (2011). Novel functions for insulin in bone. Bone. 50(2). 452–456. 67 indexed citations
15.
16.
Wu, Joy Y., Piia Aarnisalo, Murat Bastepe, et al.. (2011). Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. Journal of Clinical Investigation. 121(9). 3492–3504. 80 indexed citations
17.
DeMambro, Victoria, Masanobu Kawai, Thomas L. Clemens, et al.. (2009). A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. Journal of Endocrinology. 204(3). 241–253. 25 indexed citations
18.
DiGirolamo, Douglas J., Aditi Mukherjee, Keertik Fulzele, et al.. (2007). Mode of Growth Hormone Action in Osteoblasts. Journal of Biological Chemistry. 282(43). 31666–31674. 80 indexed citations
19.
Fulzele, Keertik, Douglas J. DiGirolamo, Zhongyu Liu, et al.. (2007). Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action. Journal of Biological Chemistry. 282(35). 25649–25658. 118 indexed citations
20.
Zayzafoon, Majd, Keertik Fulzele, & Jay M. McDonald. (2004). Calmodulin and Calmodulin-dependent Kinase IIα Regulate Osteoblast Differentiation by Controlling c-fos Expression. Journal of Biological Chemistry. 280(8). 7049–7059. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid J. Poulton Breakdown of academic impact, for papers by Chris Pászty Breakdown of academic impact, for papers by Angela Oranger Breakdown of academic impact, for papers by S Bord Breakdown of academic impact, for papers by Yuiko Sato Breakdown of academic impact, for papers by Denise Dwyer Breakdown of academic impact, for papers by Riku Kiviranta Breakdown of academic impact, for papers by Shinsuke Kido Breakdown of academic impact, for papers by S. C. Manolagas Breakdown of academic impact, for papers by Elizabeth Allan
Rankless by CCL
2026